Form 4: Guardant Health Executive Craig Eagle Reports Stock Transactions
SEC Form 4 Filing
Craig Eagle, Chief Medical Officer of Guardant Health, reports the vesting and subsequent tax withholding related to restricted stock units.
Summary
- On March 15, 2025, Craig Eagle, the Chief Medical Officer of Guardant Health, Inc., reported transactions involving the company's common stock.
- These transactions included the vesting of 1,401 restricted stock units and the subsequent withholding of 500 shares by the company to cover tax obligations.
- Following these transactions, Eagle directly owns 30,514 shares of Guardant Health common stock and 7,010 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their stock transactions. It allows investors to monitor the actions of key executives and their potential impact on the company's stock.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they represent routine vesting and tax withholding.
Key Dates
| Date | Description |
|---|---|
| June 9, 2023 | Date of restricted stock unit award grant. |
| June 15, 2024 | 33% of the shares subject to the restricted stock unit award vested. |
| March 15, 2025 | Date of reported transactions: vesting of restricted stock units and tax withholding. |
| March 18, 2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.